Prognostic Value of Composite Biomarkers Integrating Insulin Resistance and Coronary Inflammation for Major Adverse Cardiovascular Events in Post-PCI Patients with Coronary Artery Disease Across Glycemic Status: A Prospective Cohort Study
Journal of Inflammation Research · 2026-09 · Volume 19 · 1-13
DOI: 10.2147/jir.s605148 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Journal of Inflammation Research, 2026-09. Verfasst von Zixiang Ye und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Chinese Academ…. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Background
The study aimed to assess the prognostic utility of composite Insulin resistance (IR)- various inflammation biomarkers for predicting poor outcomes in coronary artery disease (CAD) patients stratified by glycemic status.
Methods
The prospective cohort included 1947 CAD patients undergoing PCI with pre-procedural coronary computed tomography angiography. Novel composite biomarkers integrating insulin resistance and inflammation (TyG-hsCRP, CTI, and TyG-fat attenuation index [FAI]) were constructed and calculated. Patients were categorized by glycemic status (normoglycemia, prediabetes, diabetes). Three-year follow-up tracked MACE (all-cause death, non-fatal myocardial infarction, unplanned revascularization). Analyses involved Cox regression, Kaplan-Meier curves, restricted cubic splines, receiver operating characteristic curves, and subgroup analyses.
Results
MACE occurred in 171 patients (8.8%). After multivariable adjustment, high versus low biomarker levels were associated with increased MACE risk: hazard ratio (HR) 1.23 (95% CI, 1.03-1.74; P=0.025) for TyG-hsCRP, 1.39 (95% CI, 1.04-2.04; P=0.032) for CTI, and 2.32 (95% CI, 1.67-3.25; P 0.05).
Conclusion
Composite biomarkers integrating IR and inflammation provide modest incremental value in predicting MACE in CAD patients. The predictive utility of these biomarkers is modulated by underlying glycemic status, highlighting the role of local coronary inflammation and supporting their potential integration into risk stratification.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, Peopl…
- Cardiometabolic Medicine Center, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
- National Clinical Research Center for Cardiovascular Diseases, Beijing, People's Republic of China.
- Department of Radiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
Zitieren
APA
Ye, Z., Liu, C., Xie, E., Wang, H. Y., Song, C., Zhang, R., & Dou, K. (2026). Prognostic Value of Composite Biomarkers Integrating Insulin Resistance and Coronary Inflammation for Major Adverse Cardiovascular Events in Post-PCI Patients with Coronary Artery Disease Across Glycemic Status: A Prospective Cohort Study. Journal of Inflammation Research, Volume 19, 1-13. https://doi.org/10.2147/jir.s605148
Vancouver
Ye Z, Liu C, Xie E, Wang HY, Song C, Zhang R, et al. Prognostic Value of Composite Biomarkers Integrating Insulin Resistance and Coronary Inflammation for Major Adverse Cardiovascular Events in Post-PCI Patients with Coronary Artery Disease Across Glycemic Status: A Prospective Cohort Study. Journal of Inflammation Research. 2026;Volume 19:1-13. doi:10.2147/jir.s605148
BibTeX
@article{Ye2026,
author = {Ye, Zixiang and Liu, Chenyue and Xie, Enmin and Wang, Hao-Yu and Song, Chenxi and Zhang, Rui and Dou, Kefei},
title = {Prognostic Value of Composite Biomarkers Integrating Insulin Resistance and Coronary Inflammation for Major Adverse Cardiovascular Events in Post-PCI Patients with Coronary Artery Disease Across Glycemic Status: A Prospective Cohort Study},
journal = {Journal of Inflammation Research},
year = {2026},
volume = {Volume 19},
pages = {1--13},
doi = {10.2147/jir.s605148}
}
EUVIMED